Reclassification analyses using the IDI and NRI showed a trend toward improved risk stratification after incorporating cMyC; however, these differences were not statistically significant.
← all excerpts
Prognostic value of point-of-care testing for cardiac myosin-binding protein C in early risk assessment of acute myocardial infarction: a prospective cohort study.
1
—
—